ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
93,480.86
-1.65%
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs Yen
158.072
-0.10%
Brent Oil
76.82
1.09%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Milestone Pharmaceuticals Inc (MIST)

  7. Milestone Pharmaceuticals Inc (MIST) ニュース

MIST

Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MIST
日付受信時刻ニュースソース見出しコード企業名
2025/01/0722 : 00GlobeNewswire Inc.Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/11/2514 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/11/1306 : 38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/11/1306 : 36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/11/1223 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/11/1221 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/09/0421 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/0905 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/08/0905 : 13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1805 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1805 : 16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1805 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1805 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1707 : 06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1605 : 41Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1605 : 38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1605 : 36Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1605 : 34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/07/1605 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/05/2920 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/05/2221 : 00GlobeNewswire Inc.Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT AwarenessNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/05/1320 : 34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
2024/05/1319 : 59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
2024/03/0423 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MIST

最近閲覧した銘柄

NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
CCOM
US30
US 30
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
COIN
DOGEUSD
Dogecoin
CCOM
US100
US Tech 100
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
FX
USDJPY
US Dollar vs Yen
NASDAQ
MSFT
Microsoft
COIN
ADAUSD
Cardano
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有